Prothena Stock Price (NASDAQ:PRTA)

Add to My Stocks
$52.5 $0.74 (1.43%) PRTA stock closing price Mar 24, 2017 (Closing)
YOUR DAILY UPDATE ON
PRTA
Prothena
24 MAR 2017
amigobulls logo
PRTA hand_up
PRTA vs S&P 500
Closing Price: Mar 24, 2017
PRTA
$52.5 ( 1.43%)
S&P 500
2344 ( -0.08%)
PRTA
52 Week Price Range
1 Year Return: 28.4%
Q4 Growth*
Poor
Profitable ?
No
net image
2016 Q4 Net Loss
-15104.7%
home image
Rating
PRTA POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Prothena Snapshot Video

11 5 2

PRTA Stock Details

Prev Close* : $51.76
Market Cap:
$1.84B
Day Low: $51.71
52 Week Low: $33.53
Open: $52
Volume: 180981
Day High: $53.04
52 Week High: $68.18
Dividend:
N/A

Latest Stock Market News

Latest Articles

Prothena News - From Partners

PRTA Stockcharts

View PRTA PE ratio, PS ratio stocks charts and compare with peers.
PRTA Chart
Note: Compare Prothena stock price history with the index and industry peers.

Prothena Valuation

PS ratio (
price to sales ratio
)
1713.68
PB ratio (
price to book ratio
)
4.49

PRTA Industry Peers

Company Price Change (%)
Avexis (AVXS)75.142.3 (3.16%)
Kythera Biopharma (KYTH)74.980 (0%)
Roche Holdings (RHHBY)31.910.18 (0.57%)
Neuroderm (NDRM)25.90.1 (0.38%)
Voyager Therapeutics (VYGR)11.560.12 (1.05%)
Cynapsus Therapeutics (CYNA)40.480 (0%)
Intec Pharma (NTEC)5.10.05 (0.99%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Prothena Corporation PLC Stock News - Partner Headlines

Prothena Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.06M1.6M50.85M0.67M2.65M
Net Income-160.11M-80.61M-7.15M-40.99M-41.41M
Total Operating Expense-81.53M57.5M41.1M44.05M
view Prothena Corporation PLC income statement
balance sheet20152014201320122011
Total Assets385.23M304.11M182.41M129.28M3.61M
Total Liabilities24.56M14.22M9.14M2.79M10.05M
Shareholders Equity360.66M289.88M173.27M126.48M-6.43M
view Prothena Corporation PLC balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities11.47M1.37M5.67M-7.22M6.61M
Net Cash From (Used By) Operating Activities-62.45M-0.68M-32.09M-42.07M-19.69M
Increase (Decrease) In Prop Plant And Equipment-1.38M-0.49M-0.53M-1.3M-0.51M
view Prothena Corporation PLC cashflow statement

Prothena Stock Message Board

Prothena stock lost 1.43 %, and the last close price as of 24 Mar, 2017 is 52.5 for PRTA stock. Stock price or share price can be used to find the total market value of a company. Prothena market cap stands at 1.82B as of 24 Mar, 2017. Prothena valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Prothena stock price and Prothena share price mean the same thing. The volume number in Prothena stock quote data shows the number of shares traded. For Ex: 180981 Prothena shares were traded as of last trading day, as seen from Prothena stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of PRTA, view Prothena stock price history.